隐藏的危险:超吸收性聚合物珠作为儿童肠道阻塞的原因
SaraPettey Sandifer1, Alicia C Greene2, Quincy Erturk1
1The Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
The Journal of surgical research
|October 2, 2025
概括
摄入超吸收聚合物 (SAP) 珠子可能会导致儿童患有危险的肠道阻塞. 实验室研究表明,超质剂和透性药可以缩小这些珠子,从而避免手术.
科学领域:
- 儿科手术 儿科手术
- 胃肠病学 胃肠病学
- 材料科学 材料科学 材料科学
背景情况:
- 摄入超吸收聚合物 (SAP) 珠子对儿童来说是一个重大风险,往往导致肠道阻塞.
- 对于SAP珠引起的肠道阻塞,经常需要进行手术.
研究的目的:
- 审查有关儿科SAP珠子摄入和肠道阻塞的现有文献.
- 为了研究体外策略,以收缩扩大的SAP珠,以潜在地防止手术.
主要方法:
- 在儿童中进行了SAP珠子摄入病例的文献审查.
- 在模拟的肠道环境中使用SAP珠进行了体外实验.
- 测试了各种超积剂和透性药,以测试它们减少珠子大小的有效性.
主要成果:
- 鉴定了87例小儿SAP珠诱导肠道阻塞的病例,超声波在诊断方面比X线图更有效.
- 85.6%的患者需要进行外科肠切除术,重复手术很常见.
- 在体外,GoLYTELY在24小时内将SAP珠子的大小减少了35.17%,超过了其他测试剂的性能.
结论:
- SAP珠子对儿科患者构成相当大的风险,需要及时管理.
- 超体剂和透性药在减少SAP珠子大小方面表现有前途,可能提供一种非手术治疗选择.
相关概念视频
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
574
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
574
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
621
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
621
Drugs for Treatment of Constipation-Predominant IBS
724
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
724
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
529
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
529
Prevention of Further Absorption of Poison
1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Drugs for Treatment of Diarrhea-Predominant IBS
634
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
634


